Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design

Viegas, Edna O; Kroidl, Arne; Munseri, Patricia J; Missanga, Marco; Nilsson, Charlotta; Tembe, Nelson; Bauer, Asli; Joachim, Agricola; Joseph, Sarah; Mann, Philipp; +16 more... Geldmacher, Christof; Fleck, Sue; Stöhr, Wolfgang; Scarlatti, Gabriella; Aboud, Said; Bakari, Muhammad; Maboko, Leonard; Hoelscher, Michael; Wahren, Britta; Robb, Merlin L; Weber, Jonathan; McCormack, Sheena; Biberfeld, Gunnel; Jani, Ilesh V; Sandström, Eric; Lyamuya, Eligius; (2018) Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design. PLOS ONE, 13 (11). e0206838-e0206838. DOI: https://doi.org/10.1371/journal.pone.0206838

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pone.0206838

Abstract

Share

Download

Filename: journal.pone.0206838.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar